Dietary Management of Chronic Pancreatitis

Core Dietary Principles

Patients with chronic pancreatitis should consume a well-balanced diet with normal fat content (approximately 30% of total energy), unless steatorrhea symptoms cannot be controlled despite adequate pancreatic enzyme replacement therapy 1, 2, 3
The American Gastroenterological Association recommends a well-balanced, unrestricted diet with no need for fat limitation for patients with normal nutritional status 1, 2, 3, 4
Fat intake can comprise approximately 30-33% of total energy intake, which has been shown to be well tolerated and associated with improvements in nutritional status and pain control 1, 2
Malnourished patients should consume high-protein (1.0-1.5 g/kg body weight), high-energy food distributed across 5-6 small meals per day 1, 2, 3, 4

The European Society for Clinical Nutrition and Metabolism recommends avoiding very high fiber diets as they increase flatulence, fecal weight, and fat losses 1, 2, 3
Fat restriction is only necessary if steatorrhea symptoms persist despite adequate pancreatic enzyme supplementation and exclusion of bacterial overgrowth 1, 2, 3

Approximately 80% of patients can be adequately managed with normal food supplemented by pancreatic enzymes alone 1, 5
10-15% of patients require oral nutritional supplements (ONS) when caloric and protein goals cannot be met through regular meals and counseling 1, 5

The American College of Gastroenterology recommends screening for deficiencies in vitamins A, D, E, and K at least every 12 months 1, 6, 4
Vitamin D deficiency is particularly common (58-78% of patients) and requires monitoring with supplementation of 38 μg (1520 IU)/day orally or 15,000 μg (600,000 IU) intramuscularly 4

The European Society for Clinical Nutrition and Metabolism recommends not continuing outdated low-fat dietary restrictions that were historically recommended but are now contraindicated unless steatorrhea is uncontrolled 1, 2
Do not rely solely on BMI for nutritional assessment as it fails to detect sarcopenia in obese patients with chronic pancreatitis 6

Patients with chronic pancreatitis should consume a well-balanced diet with normal fat content, approximately 30-33% of total energy, without fat restriction unless steatorrhea remains uncontrolled despite optimal therapy, as recommended by the Clinical Nutrition guideline 7

First-line treatment for malabsorption in chronic pancreatitis should be to optimize pancreatic enzyme replacement therapy (PERT) dosing, according to the Clinical Nutrition guideline 7
Small intestinal bacterial overgrowth (SIBO) should be ruled out, as it occurs in up to 92% of patients with pancreatic exocrine insufficiency and can mimic or worsen malabsorption, as reported by the Proceedings of the Nutrition Society 8
MCT oil should only be considered as a third-line treatment after PERT optimization and SIBO treatment have failed, as recommended by the Clinical Nutrition guideline 7

Semi-elemental formulas containing MCT are more appropriate for jejunal feeding compared to polymeric formulas, particularly in patients requiring nasojejunal or long-term jejunostomy access, according to the Clinical Nutrition guideline 9

Ensure adequate PERT dosing, and consider adding a proton pump inhibitor if response to PERT is suboptimal, as recommended by the Proceedings of the Nutrition Society 8
Test for and treat SIBO if symptoms persist despite adequate PERT, according to the Proceedings of the Nutrition Society 8
Consider MCT-containing oral nutritional supplements only if malabsorption symptoms continue after PERT optimization and SIBO treatment, as recommended by the Clinical Nutrition guideline 7
For enteral nutrition, use semi-elemental formulas with MCT for jejunal feeding, as recommended by the Clinical Nutrition guideline 9